Optovue has received 510(k) clearances from the FDA for its AngioAnalytics OCT angiography blood vessel measurement technology and for its 3-D projection artifact removal software, as well as expanded clearance for noncontact, quantitative measurements of the epithelial and stromal layers of the cornea, or epithelial thickness mapping, according to press releases.
AngioAnalytics offers objective data and analysis with the AngioVue OCTA technology by creating color-encoded maps of the vessel densities of the retina or optic nerve, while the 3-D PAR technology improves OCTA image quality, the
Uncategorized